283 related articles for article (PubMed ID: 30098776)
1. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
Lechner M; Chakravarthy AR; Walter V; Masterson L; Feber A; Jay A; Weinberger PM; McIndoe RA; Forde CT; Chester K; Kalavrezos N; O'Flynn P; Forster M; Jones TM; Vaz FM; Hayes DN; Fenton TR
Oral Oncol; 2018 Aug; 83():32-37. PubMed ID: 30098776
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
3. p16 immunostaining in cytology specimens: its application, expression, interpretation, and challenges.
Ribeiro EA; Maleki Z
J Am Soc Cytopathol; 2021; 10(4):414-422. PubMed ID: 33422456
[TBL] [Abstract][Full Text] [Related]
4. Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
Saba NF; Dinasarapu AR; Magliocca KR; Dwivedi B; Seby S; Qin ZS; Patel M; Griffith CC; Wang X; El-Deiry M; Steuer CE; Kowalski J; Shin DM; Zwick ME; Chen ZG
PLoS One; 2020; 15(9):e0238497. PubMed ID: 32986729
[TBL] [Abstract][Full Text] [Related]
5. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
[TBL] [Abstract][Full Text] [Related]
6. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16
Pakdel F; Farhadi A; Pakdel T; Andishe-Tadbir A; Alavi P; Behzad-Behbahani A; Ashraf MJ
Braz J Microbiol; 2021 Mar; 52(1):195-206. PubMed ID: 33169334
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
[TBL] [Abstract][Full Text] [Related]
8. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
[TBL] [Abstract][Full Text] [Related]
10. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature.
Masand RP; El-Mofty SK; Ma XJ; Luo Y; Flanagan JJ; Lewis JS
Head Neck Pathol; 2011 Jun; 5(2):108-16. PubMed ID: 21305368
[TBL] [Abstract][Full Text] [Related]
11. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
12. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region.
Prigge ES; Toth C; Dyckhoff G; Wagner S; Müller F; Wittekindt C; Freier K; Plinkert P; Hoffmann J; Vinokurova S; Klussmann JP; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2015 Apr; 136(7):1589-99. PubMed ID: 25104331
[TBL] [Abstract][Full Text] [Related]
13. Correlation of p16 immunostaining in cell-blocks with corresponding tissue specimens for squamous cell carcinomas of the oropharynx.
Song SJ; Jalaly JB
Cytopathology; 2021 Jan; 32(1):100-107. PubMed ID: 32886831
[TBL] [Abstract][Full Text] [Related]
14. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.
Kong CS; Narasimhan B; Cao H; Kwok S; Erickson JP; Koong A; Pourmand N; Le QT
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):553-61. PubMed ID: 19427557
[TBL] [Abstract][Full Text] [Related]
15. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
16. ROC analysis of p16 expression in cell blocks of metastatic head and neck squamous cell carcinoma.
Wilson BL; Israel AK; Ettel MG; Lott Limbach AA
J Am Soc Cytopathol; 2021; 10(4):423-428. PubMed ID: 33906829
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of p16 expression in FNA specimens from head and neck squamous cell carcinoma and correlation with HPV status.
Abi-Raad R; Prasad ML; Gilani S; Garritano J; Barlow D; Cai G; Adeniran AJ
Cancer Cytopathol; 2021 May; 129(5):394-404. PubMed ID: 33369885
[TBL] [Abstract][Full Text] [Related]
18. Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.
Zhao N; Ang MK; Yin XY; Patel MR; Fritchie K; Thorne L; Muldrew KL; Hayward MC; Sun W; Wilkerson MD; Chera BS; Hackman T; Zanation AM; Grilley-Olson JE; Couch ME; Shockley WW; Weissler MC; Shores CG; Funkhouser WK; Olshan AF; Hayes DN
Br J Cancer; 2012 Jul; 107(3):482-90. PubMed ID: 22735904
[TBL] [Abstract][Full Text] [Related]
19. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker?
Hoffmann M; Tribius S; Quabius ES; Henry H; Pfannenschmidt S; Burkhardt C; Görögh T; Halec G; Hoffmann AS; Kahn T; Röcken C; Haag J; Waterboer T; Schmitt M
Cancer Lett; 2012 Oct; 323(1):88-96. PubMed ID: 22484467
[TBL] [Abstract][Full Text] [Related]
20. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]